ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,526, issued on June 23, was assigned to Chugai Seiyaku K.K. (Tokyo) and Agency for Science Technology & Research (Singapore).
"Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of use" was invented by Katja Fink (Singapore), Cheng-I Wang (Singapore), Lisa Fong Poh Ng (Singapore), Laurent Renia (Singapore), Zenjiro Sampei (Gotemba City, Japan) and Xing'er Christine Koo (Singapore).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides anti-DENV antibodies having a cross-reactivity to ZIKV and methods of making and using the same. The anti-DENV antibodies have uses that include treating or preventing ZIKV in...